SIPONIMOD
siponimod 250 microgram tablet, 12
SIPONIMOD (12172P)
12172P
Manner of administration:Oral
Restriction 16347
Indication: Multiple sclerosis
Treatment phase: Initial treatment
Restriction 16303
Indication: Multiple sclerosis
Treatment phase: Continuing treatment (including recommencement of treatment)
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 12 | # of repeats: 0 | DPMQ: $229.54 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Mayzent | |||||